Greece
· Delayed Price · Currency is EUR Unibios Holdings Statistics
Total Valuation
ATH:BIOSK has a market cap or net worth of EUR 35.48 million. The enterprise value is 39.71 million.
| Market Cap | 35.48M |
| Enterprise Value | 39.71M |
Important Dates
The next estimated earnings date is Tuesday, September 30, 2025.
| Earnings Date | Sep 30, 2025 |
| Ex-Dividend Date | Sep 12, 2024 |
Share Statistics
ATH:BIOSK has 16.89 million shares outstanding. The number of shares has increased by 0.87% in one year.
| Current Share Class | 16.89M |
| Shares Outstanding | 16.89M |
| Shares Change (YoY) | +0.87% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 35.18.
| PE Ratio | 35.18 |
| Forward PE | n/a |
| PS Ratio | 2.41 |
| PB Ratio | 2.03 |
| P/TBV Ratio | 3.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 237.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.28, with an EV/FCF ratio of -57.86.
| EV / Earnings | 38.69 |
| EV / Sales | 2.70 |
| EV / EBITDA | 15.28 |
| EV / EBIT | 18.51 |
| EV / FCF | -57.86 |
Financial Position
The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.42.
| Current Ratio | 2.14 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 2.82 |
| Debt / FCF | -10.67 |
| Interest Coverage | 6.21 |
Financial Efficiency
Return on equity (ROE) is 6.20% and return on invested capital (ROIC) is 5.72%.
| Return on Equity (ROE) | 6.20% |
| Return on Assets (ROA) | 4.83% |
| Return on Invested Capital (ROIC) | 5.72% |
| Return on Capital Employed (ROCE) | 9.86% |
| Revenue Per Employee | 186,304 |
| Profits Per Employee | 12,990 |
| Employee Count | 79 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.27 |
Taxes
In the past 12 months, ATH:BIOSK has paid 525,882 in taxes.
| Income Tax | 525,882 |
| Effective Tax Rate | 33.88% |
Stock Price Statistics
The stock price has increased by +68.00% in the last 52 weeks. The beta is 0.72, so ATH:BIOSK's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +68.00% |
| 50-Day Moving Average | 1.77 |
| 200-Day Moving Average | 1.59 |
| Relative Strength Index (RSI) | 66.76 |
| Average Volume (20 Days) | 56,271 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ATH:BIOSK had revenue of EUR 14.72 million and earned 1.03 million in profits. Earnings per share was 0.06.
| Revenue | 14.72M |
| Gross Profit | 5.87M |
| Operating Income | 2.15M |
| Pretax Income | 1.55M |
| Net Income | 1.03M |
| EBITDA | 2.47M |
| EBIT | 2.15M |
| Earnings Per Share (EPS) | 0.06 |
Balance Sheet
The company has 3.09 million in cash and 7.32 million in debt, giving a net cash position of -4.23 million or -0.25 per share.
| Cash & Cash Equivalents | 3.09M |
| Total Debt | 7.32M |
| Net Cash | -4.23M |
| Net Cash Per Share | -0.25 |
| Equity (Book Value) | 17.46M |
| Book Value Per Share | 1.03 |
| Working Capital | 8.41M |
Cash Flow
In the last 12 months, operating cash flow was 149,435 and capital expenditures -835,731, giving a free cash flow of -686,296.
| Operating Cash Flow | 149,435 |
| Capital Expenditures | -835,731 |
| Free Cash Flow | -686,296 |
| FCF Per Share | -0.04 |
Margins
Gross margin is 39.86%, with operating and profit margins of 14.58% and 6.97%.
| Gross Margin | 39.86% |
| Operating Margin | 14.58% |
| Pretax Margin | 10.55% |
| Profit Margin | 6.97% |
| EBITDA Margin | 16.76% |
| EBIT Margin | 14.58% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.95%.
| Dividend Per Share | 0.02 |
| Dividend Yield | 0.95% |
| Dividend Growth (YoY) | 66.67% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -0.87% |
| Shareholder Yield | 0.09% |
| Earnings Yield | 2.89% |
| FCF Yield | -1.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on February 10, 2017. It was a reverse split with a ratio of 0.2.
| Last Split Date | Feb 10, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
ATH:BIOSK has an Altman Z-Score of 2.68 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.68 |
| Piotroski F-Score | 6 |